AKT1 and neoplasm: GSK690693 is a novel ATP-competitive inhibitor of AKT that inhibits proliferation and induces apoptosis in a subset of tumor cells with a potency consistent with the intracellular inhibition of AKT kinase activity in vitro and in vivo(16–18).